Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Little Green Pharma Ltd. ( (AU:LGP) ) has provided an update.
Little Green Pharma Ltd. has released the results of its General Meeting of shareholders held on 22 May 2026. The company reported that the sole resolution put to shareholders, an approval to issue consideration shares, was passed on a poll with an overwhelming majority of votes in favour.
The successful approval to issue consideration shares provides Little Green Pharma with shareholder backing to proceed with its planned equity-based transaction. This outcome supports the company’s capital and corporate strategy and may facilitate further growth initiatives or acquisitions aligned with its medicinal cannabis operations.
The most recent analyst rating on (AU:LGP) stock is a Buy with a A$0.18 price target. To see the full list of analyst forecasts on Little Green Pharma Ltd. stock, see the AU:LGP Stock Forecast page.
More about Little Green Pharma Ltd.
Little Green Pharma Ltd. is an Australian-listed company on the ASX under the ticker LGP. It operates in the pharmaceutical and medical cannabis sector, focusing on the development and supply of medicinal cannabis products for patients and healthcare markets.
Average Trading Volume: 130,955
Technical Sentiment Signal: Sell
Current Market Cap: A$30.59M
For detailed information about LGP stock, go to TipRanks’ Stock Analysis page.